Abstract:In the continuous combat against diseases, there is the need for tools that enable an improved diagnostic efficiency towards higher information density combined with reduced time-to-result and cost. Here, a novel fully integrated microfluidic platform, the Evalution™, is evaluated as a potential solution to this need. Encoded microparticles combined with channel-based microfluidics allow a fast, sensitive and simultaneous detection of several disease-related biomarkers. Since the binary code is represented by physically present holes, 210 different codes can be created that will not be altered by light or chemically induced degradation. Exploiting the unique features of this multiplex platform, hybridization chain reaction (HCR) is explored as a generic approach to reach the desired sensitivity. Compared to a non-amplified reference system, the sensitivity was drastically improved by a factor of 104, down to low fM LOD values. Depending on the HCR duration, the assay can be tuned for sensitivity or total assay time, as desired. The huge potential of this strategy was further demonstrated by the successful detection of a multiplex panel of six different nucleic acid targets including viruses and bacteria. The ability to not only discriminate these two categories but, with the same effort, also virus strains (human adenovirus and human bocavirus), virus subtypes (human adenovirus type B and D) and antibiotic-resistant bacteria (Streptococcus pneumonia), exemplifies the specificity of the developed approach. The effective, yet highly simplified, isothermal and protein-enzyme-free signal amplification tool reaches an LOD ranging from as low as 33 ± 4 to 151 ± 12 fM for the different targets. Moreover, direct detection in a clinically relevant sample matrix was verified, resulting in a detection limit of 309 ± 80 fM, approximating the low fM levels detectable with the gold standard analysis method, PCR, without the drawbacks related to protein enzymes, thermal cycling and elaborate sample preparation steps. The reported strategy can be directly transferred as a generic approach for the sensitive and specific detection of various target molecules in multiplex. In combination with the high-throughput capacity and reduced reagent consumption, the Evalution™ demonstrates immense potential in the next generation of diagnostic tools towards more personalized medicine.

A versatile quantitation platform based on platinum nanoparticles incorporated volumetric bar-chart chip for highly sensitive assays

Integration of platinum nanoparticles with a volumetric bar-chart chip for biomarker assays.

CRISPR-Cas12a Coupled with Platinum Nanoreporter for Visual Quantification of SNVs on a Volumetric Bar-Chart Chip.

A Microfluidic Platform With Digital Readout And Ultra-Low Detection Limit For Quantitative Point-Of-Care Diagnostics

A Multistage Volumetric Bar Chart Chip For Visualized Quantification Of Dna

Gold Nanoparticle Probe-Assisted Antigen-Counting Chip Using SEM.

Nanozyme‐Catalyzed Metasurface Plasmon Sensor‐Based Portable Ultrasensitive Optical Quantification Platform for Cancer Biomarker Screening

Sensitive, Quantitative Naked-Eye Biodetection with Polyhedral Cu Nanoshells

Nanoporous Glass Integrated in Volumetric Bar-Chart Chip for Point-of-Care Diagnostics of Non-Small Cell Lung Cancer.

A Portable Microfluidic Platform for Ultra-Sensitive Detection of Ovarian Cancer Biomarkers Via Cascade Signal Amplification

Competitive volumetric bar-chart chip with real-time internal control for point-of-care diagnostics.

A portable colorimetric point-of-care testing platform for MicroRNA detection based on programmable entropy-driven dynamic DNA network modulated DNA-gold nanoparticle hybrid hydrogel film

Nanoparticle Counting by Microscopic Digital Detection: Selective Quantitative Analysis of Exosomes Via Surface-Anchored Nucleic Acid Amplification.

Cleavable Energy Transfer Labeled Oligonucleotide Probe for Enhanced Isothermal Amplification Detection and Nano Digital Chip-based Readout

Nanopore-Based Fingerprint Immunoassay Based on Rolling Circle Amplification and DNA Fragmentation

Highly Sensitive Multiplex Detection of Molecular Biomarkers Using Hybridization Chain Reaction in an Encoded Particle Microfluidic Platform

An LED-Driven AuNPs-PDMS Microfluidic Chip and Integrated Device for the Detection of Digital Loop-Mediated Isothermal DNA Amplification

Nonamplification Sandwich Assay Platform for Sensitive Nucleic Acid Detection Based on Aunps Enumeration with the Dark-Field Microscope

Digital Nanofluidic Chip for Simple and Highly Quantitative Detection of HPV Target

Versatile, reusable and highly sensitive SERS-based point-of-care testing microplatform for reliable ATP detection

Rolling Circle Amplification Combined with Gold Nanoparticles-Tag for Ultra Sensitive and Specific Quantification of DNA by Inductively Coupled Plasma Mass Spectrometry